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Abstract 
Purpose: Current treatments available for chronic pain either do not provide 
patients with adequate pain relief, are invasive, expensive or cause negative side 
effects. Transcranial direct current stimulation (tDCS) delivered to the primary motor 
cortex (M1) and dorsolateral prefrontal cortex (DLPFC) brain regions has been 
identified as a potential treatment. However, the literature regarding is effectiveness is 
mixed. This study aimed to clarify if tDCS at M1 and DLPFC reduces healthy 
participants’ pain. In addition, it aimed to identify whether simultaneous stimulation 
of M1 and DLPFC results in greater pain reduction than stimulation at one cortical 
site alone.  
Method: A randomized, crossover, within-subjects, double-blinded sham 
controlled design was utilized. Twenty healthy participants (10 female; aged 18 to 59) 
underwent four conditions, 20 minutes of 1 mA anodal tDCS at M1 and DLPFC 
concurrently, M1, DLPFC and sham. A low-frequency electrical current administered 
to participants’ right volar forearm induced pain. Pain was assessed pre and post 
tDCS by pain ratings to pinprick and the electrical current level required during 
electrical stimulation to induce moderate level pain.  
Results: Analysis revealed a significant difference between pre and post tDCS 
pain assessment, however, this difference was present irrespective of tDCS condition. 
Participant habituation to low-frequency electrical stimulation may explain these 
results.  
Conclusions: TDCS within this study did not reduce healthy participants’ pain. 
This study identified methodological considerations and tDCS parameters that should 
be implemented in future replication studies to further explore tDCS as a potential 
chronic pain treatment.  
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Anodal transcranial direct current stimulation: A potential treatment for chronic pain 
Acute pain is an unpleasant physiological response of the central nervous 
system (CNS) triggered by potential tissue damaging stimulus, termed noxious stimuli 
(Chang, McDonnell & Gershwin, 2019). It is an adaptive response, alerting the 
individual to prevent/ minimize injury (Chang et al., 2019; Latremoliere & Woolf, 
2009; Moseley & Flor, 2012). Pain becomes chronic when it persists longer than three 
months or beyond normal tissue healing (Chou et al., 2015). Thus, chronic pain is 
maladaptive, as it no longer serves a protective function. Chronic pain elicits central 
sensitization, a hypersensitivity of the CNS, which results in lower pain thresholds 
and the activation of pain signals initiated by stimuli that would not typically cause a 
pain response (Fregni, Freedman & Pascual-Leone, 2007; Ji, Kohno, Moore & Woolf, 
2003; Millan, 2002; Nickel et al., 2014; Woolf, 2011). Central sensitization manifests 
as a consequence of neuroplastic changes that occur within the CNS, including 
cortical structures as a response to chronic pain (Woolf, 2011). Chronic pain can 
cause the individual significant distress and disability by negatively impacting 
wellbeing, quality of life and ability to function (Ataoğlu et al., 2013; Chizh et al., 
2007; Deloitte Access Economics, 2019; Latremoliere & Woolf, 2009; Lefaucheur et 
al., 2008). Approximately 20% of individuals with chronic pain are diagnosed with 
depression, which is significantly higher than the general population prevalence rate 
of six percent (Currie & Wang, 2004). Additionally, those with chronic pain are 30% 
more likely to be unemployed (Deloitte Access Economics, 2019). Chronic pain can 
develop from multiple aetiologies, with individuals experiencing differing symptoms 
(Henrich, Magerl, Klein, Greffrath & Treede, 2015). The exact cause or onset is 
unclear, as not all individuals experience the same level of symptomology or develop 
chronic pain following similar injuries or illnesses (Henrich et al., 2015; Kuner & 
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Flor, 2017). Additionally, each individual’s response to treatment is unique, making it 
difficult to treat (Henrich et al., 2015; Kuner & Flor, 2017). It is estimated 3.2 million 
Australians live with chronic pain, costing $73.2 billion dollars each year (Deloitte 
Access Economics, 2019). Various pain treatments are available, including 
antidepressant and opioid medication, however, no more than 30% - 50% of patients 
experience pain relief (Magrinelli, Zanette & Tamburin, 2013; Turk, Wilson & 
Cahana, 2011).  Furthermore, 80% of patients experience adverse side effects from 
these treatments (Turk et al., 2011). Surgical implantation of an electrode into the 
scalp to electrically stimulate the primary motor cortex (M1) has significantly reduced 
chronic pain symptoms for some patients (Garcia-Larrea et al., 1999; Saitoh et al., 
2001). The mechanism underlying this pain reduction is unclear, however it has been 
proposed M1 stimulation induces thalamic blood flow, which is a brain region 
implicated with chronic pain (Garcia-Larrea et al., 1999; Saitoh et al., 2001). 
However, this procedure is invasive, expensive, and not effective for all individuals 
(Garcia-Larrea et al., 1999). These findings have generated a body of research into the 
non-invasive brain stimulation techniques, repetitive transcranial magnetic 
stimulation (rTMS) and transcranial direct current stimulation (tDCS), which elicit 
neuromodulation within targeted cortical regions (Mylius, Borckardt & Lefaucheur, 
2012). Past research has identified M1 and the dorsolateral prefrontal cortex (DLPFC) 
brain regions as potential stimulation targets to reduce chronic pain symptoms 
(Boggio, Zaghi, Lopes & Fregni, 2008; Lefaucheur et al., 2017). Research has 
suggested rTMS may reduce symptoms of chronic pain, however it is expensive and 
not easily accessible, as patients are required to attend hospital for treatment 
(Lefaucheur et al., 2008). TDCS is inexpensive, safe and easy to administer, however, 
further research is required to establish its efficacy for chronic pain (O’Connell, 
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Marston, Spencer, Desouza & Wand, 2018). The development of efficacious, non-
pharmacological, non-invasive and inexpensive treatments are urgently needed to 
treat chronic pain. 
Pain processing comprises both descending and ascending pathways, 
involving both inhibitory and facilitatory neurotransmission processes in both the 
cortex and spinal dorsal horn (Bingel & Tracey 2008; Millan, 2002; Nickel et al., 
2014).  
Ascending pain pathway 
The ascending pathway of pain occurs when noxious stimuli is detected in the 
periphery, which is known as nociception (Latremoliere & Woolf, 2009). Nociception 
is an adaptive process as it assists in the prevention of further injury by initiating a 
withdrawal reflex from the noxious stimuli (Latremoliere & Woolf, 2009). 
Additionally, it generates a range of unpleasant sensory, cognitive and emotive 
sensations that results in the avoidance of further contact (Latremoliere & Woolf, 
2009). Myelinated Aδ and unmyelinated C afferent fibers located in the epidermis, 
convey nociceptive messages via synaptic transmissions terminating on the superficial 
and deep lamina of the dorsal horn of the spinal cord (Ji et al., 2003). Facilitatory 
ascending synaptic transmissions are then projected from the dorsal horn to the brain 
stem, where messages are conveyed to higher cortical regions (Bingel & Tracey, 
2008). Once the torrent of nociceptive neuronal transitions activated by noxious 
stimuli enter the spinal cord, they excite a widespread network of neurons, leading to 
central sensitization, a central excitatory state (Van Den Broeke, 2018). Primary and 
secondary hyperalgesia, a hypersensitivity to painful stimuli, are characteristics of 
central sensitization, with primary hyperalgesia manifesting at the injured site and 
secondary hyperalgesia induced in the adjacent area (LaMotte, Shain, Simone & Tsai, 
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1991; Ziegler, Magerl, Meyer & Treede, 1999). Experimental low-frequency 
subcutaneous electrical stimulation elicits central sensitization by activating both Aδ 
and C fibers (Beissner et al., 2010; Liu & Sandkühler, 1997; Ziegler, et al., 1999). 
Sauerstein et al. (2018) initiated central sensitization in healthy participants by 
inducing both primary and secondary hyperalgesia via the administration of a painful 
low-frequency electrical current of 1 Hz, to the dorsal aspect of participants’ feet 
(Sauerstein et al., 2018). Following electrical stimulation, participants reported greater 
pain to pinprick stimuli within the primary (site of stimulation) and secondary 
(adjacent to the stimulated site) areas compared to pre stimulation ratings (Sauerstein 
et al., 2018). These findings indicate low-frequency electrical stimulation induces 
primary and secondary hyperalgesia in healthy participants (Sauerstein et al., 2018). 
Validated experimental pain models tested on healthy participates allow for the 
assessment of pain processes, without the confounding factors of the multiple 
aetiologies chronic pain arises from and the various treatments and medications used 
to relive symptoms; possibly leading to the discovery of more treatment avenues for 
chronic pain (Chizh et al., 2007; Koppert et al., 2005). 
Descending pain pathway 
The descending pain pathway begins with neurotransmission originating from 
specific brain regions converging at the brain stem, which then projects inhibitory or 
facilitatory mechanisms to the spinal cord, modulating incoming nociceptive 
messages from the periphery (Bannister & Dickenson, 2017; Yarnitsky, 2015). 
Initially, the brain processes nociceptive messages received from Aδ and C fibers via 
the synaptic transition of neurotransmitter glutamate, which can interact with both N-
methyl-Dasparate (NMDA) and non-NMDA excitatory amino acid receptors (Argoff, 
2011; Vanderah, 2007). Incoming messages from the periphery are then modulated 
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and either facilitated or inhibited via the release of endorphins through opioid 
receptors activated at the periaqueductal gray (PAG) region of the midbrain  
(Vanderah, 2007). The key neurotransmitters involved within this process are 
serotonin and norepinephrine, dopamine and ϒ-aminobutyric acid (GABA) 
(Vanderah, 2007; Woolf & Salter, 2000; Yam et al., 2018).  The “pain matrix” is the 
grouping of brain regions deemed responsible for the descending pathway of pain in 
experimental models (Bingel & Tracey, 2008; Moisset & Bouhassira, 2007).  These 
brain regions include the primary and secondary somatosensory cortices, the insular 
cortex, the anterior cingulate cortex, the thalamus and the prefrontal cortex (Moisset 
& Bouhassira, 2007). Broad and sustained cortical neuronal firing responses to acute 
injury can lead to neuroplastic changes within the cortex, which assists with the 
development and maintenance of chronic pain (Hashmi et al., 2013; Moseley & Flor, 
2012; Ossipov, Morimura & Porreca, 2014).  
Transcranial Direct Current Stimulation  
TDCS is a non-invasive brain stimulation technique that is safe, inexpensive, 
has minimal side effects and is accessible to a large portion of the population 
(Kessler, Turkeltaub, Benson & Hamilton, 2012; Lefaucheur et al., 2017; Rossi, 
Hallett, Rossini & Pascual-Leone, 2009). TDCS elicits neuromodulation by sending a 
weak constant electrical current to targeted brain regions via anodal electrodes 
(emitting a positive current) and cathodal electrodes (projecting a negative current), 
affixed to the scalp (Antal et al., 2017; Cruccu et al., 2016; Fregni et al., 2005; Fregni 
et al., 2007; Moisset & Lefaucheur, 2019). The strength of the electrical current 
typically applied is between 1 mA to 2 mA, which is not strong enough to elicit action 
potentials (Lefaucheur et al., 2017). Rather, neuronal membrane resting voltages are 
augmented and brought either closer to (depolarized) or further away from 
TDCS AND CHRONIC PAIN  12 
(hyperpolarized) firing (Lefaucheur et al., 2017; Thair, Holloway, Newport & Smith, 
2017). Nitsche & Paulus (2000) examined cerebral excitability by recording motor 
evoked potentials following 1 mA anodal (a-tDCS) and cathodal (c-tDCS) tDCS 
delivered to M1. Results indicated a-tDCS was associated with a significant increase 
in motor-cortex excitability, conversely, c-tDCS elicited a decrease in excitability 
(Nitsche & Paulus, 2000). These findings confirm that a-tDCS depolarizes (excites) 
neurons, whilst c-tDCS hyperpolarizes (inhibits) neurons (Naegel et al., 2018; Thair 
et al., 2017). Thirteen minutes of tDCS induces neuromodulation that lasts up to 90 
minutes post stimulation (Ihle, Rodriguez-Raecke, Luedtke & May, 2014; Nitsche & 
Paulus, 2001).  
Neuroimaging studies have implied that a-tDCS administered to M1 and 
DLPFC may decrease pain by influencing the descending inhibitory pain process 
(Ong, Stohler & Herr 2019; Meeker et al., 2019; Moisset & Bouhassira, 2007). 
Polania, Nitsche & Paulus (2011) conducted a seed functional connectivity analysis 
following 10 minutes of 1 mA a-tDCS, c-tDCS and sham (a control condition, where 
active tDCS is delivered for 30 seconds before being ramped down for the remainder 
of the session) to M1. Analysis revealed greater functional connectivity between the 
thalamus and M1 following a-tDCS, this connectivity was not present within the c-
tDCS and sham conditions (Polania et al., 2011). These results suggest a-tDCS of M1 
modulates cortico-striato-thalamo-cortical circuits, inhibiting synaptic thalamic 
sensory pathways, which are involved in the descending inhibitory pain pathway 
(Millan, 2002; Moisset & Bouhassira, 2007; Polania et al., 2011). However, as this 
study did not record brain responses to painful stimuli, direct observations regarding 
the effect of tDCS on neuronal activity responding to pain cannot be made. This was 
addressed by Sankarasubramanian et al. (2017), who compared changes in 
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connectivity via functional magnetic resonance imaging (fMRI) to painful heat 
stimuli in a sham controlled study, following 20 minutes of 1 mA a-tDCS at M1 and 
in addition, to DLPFC. A-tDCS at both M1 and DLPFC induced functional 
connectivity changes between the ventroposterolateral and sensory nucleus of the 
thalamus, however functional connectivity strength was greater following M1 
compared to DLPFC stimulation (Sankarasubramanian et al., 2017). This suggests 
that M1 stimulation may modulate thalamic brain activity during pain perception. 
However, functional connectivity strength was greater following DLPFC compared to 
M1 stimulation between the medial dorsal, the affective nucleus, and brain regions 
associated with affective information processing (Sankarasubramanian et al., 2017). 
These findings insinuate that M1 tDCS mainly modulates functional connectivity 
within sensory networks, whereas DLPFC stimulation modulates both sensory and 
affective networks (Sankarasubramanian et al., 2017).  These neuroimaging studies 
imply that a-tDCS at M1 and DLPFC may reduce pain by differentially modulating 
neuroplastic changes within the descending inhibitory pain pathway, although the 
exact cortical mechanisms involved still remain unclear (Mylius et al., 2012; Polania 
et al., 2011; Sankarasubramanian et al., 2017; Wiech, Ploner & Tracey, 2008).  
However, these studies did not directly test participants’ level of pain pre and post 
tDCS, therefore definitive inferences cannot be drawn regarding the effectiveness of 
tDCS for pain reduction. 
Transcranial Direct Current Stimulation Primary Motor Cortex  
The application of a-tDCS at M1 has been studied in clinical populations to 
establish whether it reduces chronic pain, however results have been mixed (David, 
Moraes, Costa & Franco, 2018; O’Connell et al., 2018; Wrigley et al., 2013). Khedr et 
al. (2017) examined whether a-tDCS at M1 would decrease pain symptoms in 
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individuals diagnosed with fibromyalgia (which causes widespread chronic pain). 
Forty participants either received 10 sessions of 2 mA a-tDCS for 20 minutes or sham 
administered over 10 consecutive days (Khedr et al., 2017). Participants rated their 
level of pain on an 11-point visual analog scale (VAS), where a rating of 0 indicated 
no pain and 10, the worst imaginable pain (Khedr et al., 2017). Following the tenth 
session, participants in the a-tDCS condition reported significantly less pain than 
those in the sham group (Khedr et al., 2017). A study conducted by Ngernyam et al. 
(2015) established similar findings in participants with neuropathic chronic pain. 
Twenty participants received a single session of both sham and a-tDCS of 2 mA for 
20 minutes at M1 (Ngernyam et al., 2015). Sessions were conducted at least one week 
apart and order of conditions was randomized to prevent carry over and order effects 
(Ngernyam et al., 2015).  Participants in the a-tDCS condition reported significantly 
lower scores on a numerical rating scale for pain compared to sham, suggesting a-
tDCS was successful at reducing chronic pain within this study (Ngernyam et al., 
2015). However, findings produced by Thibaut, Carvalho, Morse, Zafonte & Fregni 
(2017) were mixed. Thirty-three participants who developed chronic pain following 
spinal cord injury either received sham or a-tDCS of 2 mA for 20 minutes at M1 
(Thibaut et al., 2017).  The study was conducted over two phases, during phase one, 
participants underwent five sessions over five consecutive days, and during phase two 
attended 10 sessions over 10 days (Thibaut et al., 2017). Participants’ reported VAS 
pain ratings were significantly lower following five sessions of a-tDCS compared to 
sham (Thibaut et al., 2017). There was no significant difference in VAS pain ratings 
following 10 sessions (Thibaut et al., 2017). Results suggest chronic pain was reduced 
following five consecutive sessions of a-tDCS, but not 10 (Thibaut et al., 2017). 
These results contradict the findings of Khedr et al. (2017), where a significant 
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reduction in pain was observed following 10 sessions of a-tDCS. Furthermore, Lewis, 
Rice, Kluger & McNair (2018) found participants’ chronic pain was not reduced 
following five consecutive sessions of 1 mA a-tDCS for 20 minutes at M1, 
contradicting results from the Thibaut et al. (2017) study. It is difficult to interpret the 
current results, as studies have not implemented methodological considerations which 
control for the confounding factors of clinical populations; such as the multiple 
ateoligies of chronic pain, differing symptoms and patient treatment plans (Henrich et 
al., 2015). Experimental studies have examined a-tDCS on healthy populations, 
however results remain mixed.  
Ihle et al. (2014) administered 1 mA a-tDCS, c-tDCS and sham at M1 for 15 
minutes to 16 healthy participants. Participants’ pain ratings to heat and pinprick 
stimuli were obtained via a numerical rating scale at baseline and post tDCS (Ihle et 
al., 2014). There was no significant difference between participants’ pain ratings pre 
and post tDCS across all conditions (Ihle et al., 2014). However, there was a non-
significant trend towards lower pain ratings within the a-tDCS condition (Ihle et al., 
2014). These results imply tDCS did not reduce participants’ pain within this study 
(Ihle et al., 2014). Conversely, a study conducted by Meeker et al. (2019) contradicted 
results obtained by Ihle et al. (2014), where participants reported pain reduction to 
thermal stimuli following a-tDCS of 1 mA for 20 minutes at M1. Similar results were 
obtained by Zandieh et al. (2013), where a-tDCS to M1 at 2 mA for 15 minutes 
significantly increased cold pain thresholds compared to c-tDCS or sham in healthy 
participants. The findings of these studies suggest a-tDCS to M1 might reduce pain in 
healthy volunteers; however further studies are required to clarify the mixed results of 
prior research (Beissner et al., 2010; Granovsky, Raz & Defrin, 2017).  
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Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex  
Although the majority of research exploring the efficacy of tDCS for pain 
reduction has targeted M1, some neuroimaging and experimental studies suggest that 
DLPFC stimulation may reduce pain by activating descending inhibitory pain 
mechanisms (Boggio et al., 2008; Mylius et al., 2012; Sankarasubramanian et al., 
2017; Wiech et al., 2008). To explore whether tDCS at DLPFC reduces pain Boggio 
et al. (2008) conducted a sham-controlled study administering 2 mA of a-tDCS for 
five minutes to DLPFC. In addition, Boggio et al. (2008) examined whether DLPFC 
a-tDCS would result in greater pain reduction than M1 a-tDCS. Pain was induced by 
electrically stimulating the right index finger of 20 healthy participants (Boggio et al., 
2008). Results indicated that a-tDCS at DLPFC increased participants’ pain 
thresholds but did not decrease pain perception (Boggio et al., 2008). Additionally, a-
tDCS at M1 decreased participants’ pain perception and increased pain thresholds, 
however, pain threshold increases within this condition were lower than following 
DLPFC stimulation (Boggio et al., 2008). Findings indicate that a-tDCS of both 
DLPFC and M1 reduced participants’ pain within this study (Boggio et al., 2008). 
Due to the differing effect on pain perception and thresholds across conditions, it can 
be speculated that stimulation at M1 and DLPFC may concurrently but differentially 
influence the descending inhibitory pain process. Mylius et al. (2012) further 
investigated whether tDCS at DLPFC reduced healthy participants pain by assessing 
tolerance to heat. Twenty-four participants underwent three conditions, 20 minutes of 
2 mA a-tDCS, c-tDCs and sham at DLPFC (Mylius et al., 2012). Pain tolerances to 
the heat stimuli were assessed pre and post tDCS (Mylius et al., 2012). Participants’ 
pain thresholds increased during DLPFC a-tDCS, no increase was observed in any 
other condition. The results of this study suggest DLPFC a-tDCS, but not c-tDCS, 
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reduces pain in healthy participants. There are no other known studies examining 
tDCS stimulation at DLPFC on healthy participants. Further studies are required 
clarify current findings.  
The current literature suggests a-tDCS of M1 and DLPFC could potentially 
reduce pain, however further research is required to clarify the results of published 
studies. This research needs to be conducted on healthy participants prior to 
continuing testing on clinical populations. This will establish whether tDCS can 
firstly reduce experimental pain, and if so, clarify the most effective tDCS parameters 
for pain reduction without the intervening confounding factors associated with 
chronic pain (Henrich et al., 2015). Once this has been clarified, further testing on 
clinical populations can recommence to establish its efficacy as a potential treatment 
for chronic pain. Furthermore, no known study has investigated whether concurrent a-
tDCS of M1 and DPLFC reduces pain. This is worth exploring, as prior research has 
suggested a-tDCS of M1 influences pain perception and sensory networks, whereas 
DLPFC stimulation influences pain thresholds and affective networks, indicating 
these brain regions may differentially modulate activity in the descending inhibitory 
pain process (Boggio et al., 2008; Sankarasubramanian et al., 2017). By concurrently 
stimulating both brain regions, this may simultaneously influence several descending 
inhibitory pain processes, which may result in greater reductions of pain compared to 
stimulation at one site alone. 
 Firstly, the aim of this study was to clarify whether a-tDCS stimulation of M1 
and DLPFC reduced pain in healthy individuals. Secondly, this study aimed to 
identify whether concurrent a-tDCS of M1 and DLPFC resulted in a greater reduction 
of pain than stimulation of each brain region independently. The current study 
administered a-tDCS to healthy adults across four conditions, M1 and DLPFC 
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concurrently, M1 alone, DLPFC alone and sham. Experimental pain was induced by 
low-frequency electrical stimulation administered to participants right volar forearm, 
this method has been validated to induce both primary and secondary hyperalgesia 
(core symptoms of chronic pain) by several studies (Sauerstein et al., 2018; Seifert, 
Kiefer, Decol, Schmelz & Maihofner, 2009). By clarifying the conflicting literature 
regarding whether a-tDCS at M1 and DLPFC reduces pain in healthy adults, and 
exploring concurrent stimulation of these brain regions as a potential treatment 
parameter, may lead to better treatments avenues for chronic pain.   
Firstly, it was hypothesized a-tDCS at M1 and DLPFC concurrently would 
result in lower pain ratings to pinprick in the primary and secondary areas and a higher 
current level during electrical stimulation to elicit moderate pain, than M1 alone, 
DLPFC alone and sham. Secondly, it was hypothesized a-tDCS at M1 would result in 
lower pain ratings to pinprick in the primary and secondary areas and a higher current 
level during electrical stimulation to elicit moderate pain than sham. Thirdly, it was 
hypothesized a-tDCS at DLPFC would result in lower pain ratings to pinprick in the 
primary and secondary areas and a higher current level during electrical stimulation to 
elicit moderate pain than sham. 
 
Method  
Design  
The following study employed a crossover, double-blinded, randomized, sham 
controlled design to evaluate the effect of tDCS on primary and secondary 
hyperalgesia induced by low-frequency electrical stimulation in healthy adults. The 
independent variables were the four tDCS conditions (a-tDCS at left M1 and DLPFC 
concurrently, a-tDCS at left M1, a-tDCS at left DLPFC and sham) and time (pre 
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tDCS (Time 1) and post tDCS (Time 2)). The first dependent variable was the 
electrical current level eliciting moderate (level 5) pain, applied to the right volar 
forearm. The second dependent variable was pain ratings to pinprick within the 
primary area, and the third, pain ratings to pinprick in the secondary area.  
The order of tDCS conditions were counterbalanced and randomized between 
and within participants in accordance with the Latin square method to eliminate any 
potential order effects (Zeelenberg & Pecher, 2015). Conditions were scheduled at 
least one week apart to minimize carry over effects (Ihle et al., 2014; Samani, 
Agboada, Jamil, Kuo & Nitsche, 2019). Double-blinding was achieved as participants 
and the experimenter obtaining pain related data were not aware of which tDCS 
condition was administered during testing sessions. A within subjects design was 
utilized to minimize potential confounding factors arising from participant individual 
differences and to achieve greater statistical power with a small sample size 
(Charness, Gneezy & Kuhn, 2012).  
Participants  
Ethics approval was granted by the Murdoch University Human Ethics 
Research Committee (Appendix A). A convenience sampling approach was utilized to 
recruit 26 participants for this study. One participant did not complete all sessions and 
five participants were eliminated, as they did not reach moderate level pain at the 
maximum safe current level of 30 mA, during electrical stimulation. A final 20 right-
handed healthy participants were included (10 males), aged between 18 and 59 (M = 
25.10, SD = 8.87). We conducted a power analysis using G*Power 3.1, which 
indicated to achieve a medium effect size of 0.3 with power of 0.8 and a p-value of 
0.05, we would require data from 24 participants (Faul, Erdfelder, Lang & Buchner, 
2007). However, past studies achieved a significant difference with between 15 to 20 
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participants (Boggio et al., 2008; Meeker et al., 2019). Due to the time restraints of a 
one-year research project, it was agreed a final sample of 20 participants would be 
adequate. Individuals who were under the age of 18 or over 65, obtained a score of 60 
or below on the Edinburg Handedness Inventory Short Form, suffered from a mental 
illness or medical condition, had epilepsy or experience seizures, had a cognitive 
impairment or intellectual disability, were pregnant or breastfeeding, taking any 
medication, wearing a pacemaker or suffering from chronic pain were ineligible to 
participate. Only right-handed participants were included within the study to avoid 
any confounding effects of handedness resulting in greater functional connectivity of 
the left hemisphere (Van Den Broeke, Hartgerink, Butler, Lambert & Mouraux, 2019; 
Polania et al., 2011).  
Participants attended four separate two-hour experimental testing sessions held 
at the Murdoch University Body and Mind Laboratory, located in the Sports Sciences 
Building. Participants were required to reschedule their appointment if they had taken 
painkillers or drunk alcohol within 24 hours, or taken illicit drugs in the week prior to 
the scheduled session. As the experimental pain procedure would not exceed 
participants’ moderate level of pain, it would be unlikely they would feel physically 
or psychologically unwell following a testing session. However, should this occur, 
participants were provided with the contact details of the Murdoch Medical and/ or 
Counseling Centre to arrange an appointment at no cost to the participant. Psychology 
students who registered through the Murdoch University Research Participant Portal 
were given research credits for their course. Non-psychology students and external 
participants were incentivized by going into a draw to win a $100.00 voucher.  
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Apparatuses  
Transcranial Direct Current Stimulation  
TDCS was delivered to the scalp by a Chattanooga Ionto TM Dual Channel 
Iontophoresis System, powered by a 9 Volt battery or similar, with a maximum output 
of 8 mA (Guildford Surrey, UK; Appendix B). The positive electrical current was 
delivered by two active anodal rubber electrodes (5 cm x 5 cm). A cathodal rubber 
electrode (5 cm x 7 cm) completed the electrical circuit. All electrodes were encased 
in sponges. To assist with the conductance of the electrical current, 5 ml of saline was 
applied to the anodal sponges and 7 ml applied the cathodal sponge; additionally, gel 
was applied to the side of the sponges that made contact with the scalp (Appendix B). 
Software 
 To locate participants’ M1 and DLPFC cortical regions the EZ-EEG program 
was utilized (Borckardt & Hanlon, 2015).  
Low-frequency electrical stimulation  
The low-frequency electrical stimulation pain model was generated by a 
constant current stimulator (DS7A; Digitimer, Welwyn Garden City, UK; Appendix 
B). The current was delivered by a custom built stimulating electrode with 25 copper 
pins, .2-mm-diameter tips, protruding .5 mm from the surface of a 2 cm x 2 cm 
perspex block, held in place by a firm velcro strap (Vo & Drummond, 2014; Vo & 
Drummond, 2016). A 3 cm x 3.5 cm ground plate was attached 2 cm to the left of the 
conditioning electrode to complete the electrical circuit (Vo & Drummond, 2016).   
The electrical current was set to the frequency of 1 Hz with a pulse width of 0.5 ms 
and a 10 ms delay, up to a maximum of 30 mA (these parameters active Aδ and C 
fibers; Sauerstein et al., 2018; Vo & Drummond, 2016). The strength of the electrical 
current was monitored via a Current Reader Box.  
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Pinprick sensitivity  
To assess sensitivity to pain and sharpness a single use Neurotip was inserted 
into a calibrated spring mechanism exerting a force of 40 g (Appendix B). It was 
administered to participants right volar forearm at a 90° angle for 2 seconds 
(Neuropen®; Owen Mumford, Oxfordshire, UK) (Finch, Price & Drummond, 2019; 
Vo & Drummond, 2013).  
Visual Analogue Scale  
 Participants rated pain and sharpness to electrical and pinprick stimuli using a 
Visual Analogue Scale (VAS), an 11-point scale ranging from 0 no pain/ sharpness to 
10 worst pain/ sharpness imaginable, with a rating of 5 indicating a moderate level of 
pain/ sharpness (Appendix B; Vo & Drummond, 2014). The VAS is recognized as a 
valid and reliable measure of obtaining pain and sharpness ratings (Bijur, Silver & 
Gallagher, 2001).  
Procedure  
 Participants attended four two-hour sessions, one session for each tDCS 
condition. At the commencement of the first session participants were required to read 
an information letter, which detailed the nature and process of the study (Appendix 
C). They then completed a screening questionnaire consent form (Appendix D), 
Edinburg Handedness Inventory Short Form (Appendix E) and Transcranial Magnetic 
Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) Safety Screen 
(Appendix F), to ensure they met all inclusion criteria and it was safe to participate 
(Meeker et al., 2019; Veale, 2014).  
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Each session followed an identical procedure. Firstly, participants right volar 
forearm was exfoliated with Solvo soap, removing dead skin cells to reduce skin 
resistance to the electrical current (Sauerstein et al., 2018; Vo & Drummond, 2014). 
Secondly, the researcher obtaining pain related data, identified the primary and 
secondary areas on the right volar forearm for the low-frequency electrical stimulation 
procedure. The grounding electrode was affixed 2 cm to the left of the electrode.  
    10 minutes    20 minutes  10 minutes                    20 minutes                  10 minutes 
Figure 1. Schematic representation of the experimental procedure and timeline  
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Figure 2. Visual representation of the primary and secondary areas for 
pinprick hyperalgesia induced by low-frequency electrical stimulation, with 
grounding electrode. Blue square marked on the right volar forearm is the primary 
area and 1 cm below the primary area is deemed the secondary area.  
Time 1 
Participants were trained to provide consistent pain and sharpness ratings in 
accordance with the VAS by responding to two Neuropen pinpricks administered to 
the right wrist. Two baseline pain and sharpness ratings were obtained, one from the 
primary area and one from the secondary area.  
Obtain moderate pain current level procedure  
Participants’ baseline current level to elicit moderate pain was then obtained. 
The stimulating electrode was placed over the primary area and secured with a velcro 
strap. Low-frequency electrical stimulation of the right volar forearm commenced, 
beginning at a 2 mA electrical current. The current was increased by 0.5 mA steps 
until the participant reported moderate pain (level 5 on the VAS).  
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Figure 3. Visual representation of the right volar forearm low-frequency 
electrical stimulation.  
Transcranial Direct Current Stimulation 
The participant was required to sit still and quietly in a comfortable armchair. 
To maintain the double-blinded procedure, tDCS was carried out by a second 
researcher that did not obtain pain ratings to pinprick and electrical stimuli. 
Additionally, the anodes were placed over left M1 and left DLPFC across all four 
conditions, however, only the channel(s) relevant to the condition were activated. The 
cathode was placed over the contralateral (right) supraorbital area for all four 
conditions. The 10-20 international system for EEG electrode placement procedure 
was followed to located left M1 (location C3 according to the EEG system) and left 
DLPFC (location F3) for anode placement (DaSilva, Volz, Bikson & Fregni, 2011; 
Fregni et al., 2005). The tDCS operator administered an electrical current of 1 mA for 
20 minutes to the target brain region(s) relevant to the condition (either at left M1 and 
DLPFC concurrently, left M1 or left DLPFC). During the sham condition a-tDCS of 1 
mA was applied to both left M1 and DLPFC, the current was ramped up over 30 
seconds and then ramped down over 10 seconds; no current was emitted for the 
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remainder of the 20 minutes. This sham procedure has been validated to mimic 
sensations associated with active tDCS to ensure participants remain blinded to 
conditions, without eliciting cortical excitability (Bachmann et al., 2010; Ihle et al., 
2014). The tDCS administration of 1 mA for 20 minutes was chosen as prior studies 
had reported a significant increase in pain thresholds following these parameters, 
whilst minimizing side-effects to participants and maintaining the integrity of the 
blinding procedure (Kessler et al., 2012; Meeker et al., 2019).  
 
 Figure 4. Visual representation of the tDCS procedure. Yellow Sponge: 
cathodal electrode in the contralateral supraorbital area; blue sponge: anodal electrode 
at DLPFC; pink sponge: anodal electrode at M1.   
Time 2 
Low-Frequency Electrical Stimulation 
Following tDCS, the participant returned to the experimenter that collected 
pain data. Post tDCS, one pinprick pain and sharpness rating was obtained from both 
the primary and secondary areas. The procedure to obtain the moderate pain current 
level was again followed (as detailed above). However the electrical current 
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commenced at that level that elicited moderate pain (level 5 on the VAS) prior to 
tDCS (Time 1). The electrical current was increased by 0.5 mA steps until the 
participant reached moderate pain. Electrical stimulation continued at that current 
level for 20 minutes. The experimenter prompted the participant to provide pain and 
sharpness ratings every minute by taping their wrist. The participant then received a 
five-minute break to minimize the effect of a potential adaptive response the electrical 
stimulation (Sauerstein et al., 2018).  
Time 3 
Following the five-minute break, the experimenter that collected pain data 
obtained one pinprick pain and sharpness rating from both the primary and secondary 
areas. The procedure to obtain the moderate pain current level was again followed. 
However the current commenced at the level that elicited moderate pain (level 5 on 
the VAS) post t-DCS (Time 2). Finally the participant completed a Non-invasive 
Brain Stimulation (NiBS) Questionnaire to ensure they did not experience any 
adverse side effects during stimulation (Appendix G). In the last session participants 
completed an exit survey (Appendix H) and were asked to indicate in which session 
they thought they received sham.  
Emergency Procedure  
 All experimenters were First Aid trained to ensure they were able to 
appropriately respond if a participant required basic medical attention. If urgent 
medical attention was required experimenters were to call an ambulance by dialing 
000 and notify security. 
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Results 
Inspection of the Edinburgh Handedness Inventory Short Form confirmed all 
participants met the criteria for right-handedness, with a reported minimum score of 
75 and maximum of 100 (M = 96.25, SD = 7.14).  
 A chi-squared goodness-of-fit test (at α = .05) was used to assess whether 
participants were able to correctly guess the sham condition. The chi-squared test was 
statistically significant χ2(1, N = 20) = 9.80, p = .002, indicating participants correctly 
guessed sham 15% of the time, which is less than chance. As an index of effect size, 
Cohen’s w was 0.70, which can be considered a large effect. To further assess 
whether participants were blinded to the sham condition, the Non-invasive Brain 
Stimulation Questionnaire subscales, itching, tingling and burning (the most 
commonly reported sensations during tDCS) were examined (Kessler et al., 2012; 
Wrigley et al., 2013). A one-way repeated measures analysis of variance (ANOVA) 
was conducted to evaluate whether participants’ reported itching, tingling and burning 
sensations were statistically significantly different across M1 & DLPFC, M1, DLPFC 
and Sham conditions.  
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Table 1 presents the descriptive statistics across all conditions.   
Table 1  
Descriptive Statistics of Itching, Tingling and Burning Sensations Across All TDCS 
Conditions.   
             Itching             Tingling            Burning 
tDCS  
Condition 
M (SD) 95% CI M (SD) 95% CI M (SD) 95% CI 
M1 & 
DLPFC 
3.00 (1.12) [2.47, 3.53] 2.45 (0.76) [2.09, 2.81] 2.10 (0.79) [1.73, 2.47] 
M1 2.55 (1.00) [2.08, 3.02] 2.15 (0.81) [1.77, 2.53] 1.45 (0.76) [1.09, 1.81] 
DLPFC 2.70 (1.08) [2.19, 3.21] 2.20 (0.89) [1.78, 2.62] 1.70 (0.86) [1.30, 2.10] 
Sham 2.5 (1.24) [1.92, 3.08] 2.55 (1.00) [2.08, 3.02] 1.60 (0.99) [1.13, 2.07] 
Note. M = mean; SD = standard deviation; CI = confidence interval.  
 The ANOVA revealed there was a non-significant difference between tDCS 
condition and itching sensations F(3, 57) = 1.94, p = .133, η2 = .09 and tingling 
sensations F(3, 57) = 2.36, p = 0.081, η2 = .11. However, there was a significant 
difference between condition and burning sensations F(3, 57) = 4.28, p = .009, η2 = 
.18. Bonferroni-adjusted pairwise comparisons revealed burning sensations during the 
M1 & DLPFC condition (M = 2.10, SD = .79) were significantly higher than the M1 
condition (M = 1.45, SD = .76), p = .022, this difference was large, with d = 0.84.  
However, there was no significant difference between burning sensations and all other 
conditions. The above results demonstrate that the tDCS effects in the active 
conditions were more pronounced than sham, indicating the tDCS procedure was 
administered correctly. However, participants were not able to distinguish between 
sham and active conditions, which suggests that participant blinding was successful.  
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Statistical Analysis of Hypotheses and Assumption Tests  
 One-way repeated measures ANOVAs (with α = 0.5) were utilized to evaluate 
the hypotheses of this study. Assumptions of the analysis were tested. Shapiro-Wilk 
statistic (p  > .05) was inspected to assess normality, which indicated, in accordance 
with this test, the majority of variables were not normally distributed. However, the 
Shapiro-Wilk statistic is sensitive and signals departures from normality when it is 
inconsequential (Allen, Bennett & Heritage, 2014; Tabachnick & Fidell, 2007). To 
further assess normality, visual measures were inspected. Additionally, skewness and 
kurtosis fell within three times the standard error of the mean for all variables, except 
two. Furthermore, a repeated measures ANOVA is considered robust to moderate 
deviations from normality (Blanca, Alarcón, Arnau, Bono & Bendayan, 2017; Guiard 
& Rasch, 2004). Due to the subjective nature of pain and robustness of the ANOVA, 
it was considered appropriate to continue with interpretation rather than performing 
transformations of the data (Bannister & Dickenson, 2017). Fmax figures for variables 
were 2.7 (tDCS conditions), 1.60 (primary area pain ratings) and 2.39 (secondary area 
pain ratings), demonstrating the assumption homogeneity of variance was not 
violated. Mauchly’s test (p > .05) indicated the assumption of sphericity was violated 
for some variables, in these instances Greenhouse-Geisser corrections were applied 
(Field, 2015). 
The Effect of tDCS on Current Level during Electrical Stimulation at Time 1 
and Time 2 
 The current level between Time 1 and Time 2 across tDCS conditions was 
analyzed to establish whether participants’ tolerance to the current level eliciting 
moderate pain resulted from tDCS. Table 2 presents the descriptive statistics for the 
intensity of the electrical current level across tDCS conditions.  
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Table 2  
Descriptive Statistics for Strength of Electrical Current at Time 1 and Time 2 Across 
All TDCS Conditions 
              Time 1             Time 2 
tDCS  
Condition 
M (SD) 95% CI M (SD) 95% CI 
M1 & 
DLPFC 
8.40 (3.82) [6.61, 10.19] 10.28 (5.65) [7.63, 12.92] 
M1 7.95 (4.15) [6.01, 9.89] 9.25 (4.77) [7.02, 11.48] 
DLPFC 8.40 (4.21) [6.43, 10.37] 10.58 (5.62) [7.94, 13.21] 
Sham 9.13 (5.46) [6.57, 11.68] 10.65 (6.32) [7.69, 13.61] 
Note. M = mean; SD = standard deviation; CI = confidence interval.  
A one-way repeated measures ANOVA was conducted to evaluate whether 
tDCS condition had an effect on the intensity of the current level required for 
participants to report a moderate level of pain.  
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Figure 5. Estimated marginal means for level of electrical current at Time 1 and Time 
2 across M1 & DLPFC, M1, DLPFC and Sham conditions.  
Figure 5 demonstrates the Sham condition required the highest current level 
for participants to report a moderate level of pain; this is followed by DLPFC, then 
M1 & DLPFC and finally the M1 condition.   
The ANOVA results revealed that the current level to elicit moderate pain 
level varied statistically significantly between Time 1 and Time 2 F(1.00, 19.00) = 
23.39, p < .001, η2 = .55; however, the current level did not vary significantly across 
tDCS conditions, F(1.95, 37.12) = 0.83, p = .441, η2 = .042; or the interaction between 
tDCS conditions and time F(1.53, 29.10) = 0.88, p = .339, η2 = .04. Results revealed 
there was a significant main effect for time, indicating the current level to elicit 
moderate pain level increased significantly from Time 1 to Time 2 irrespective of 
tDCS condition. Participant habituation to the low-frequency electrical stimulation 
may provide an explanation for these findings (Milne, Kay & Irwin, 1991; Seifert et 
al., 2009). 
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The Effect of tDCS on Pinprick Pain Ratings at Primary and Secondary Areas 
Across Time 1 and Time 2 
To assess whether tDCS decreased participants’ sensitivity to pinprick, 
participants’ pain ratings to pinprick within the primary and secondary areas at Time 
1 and Time 2 were analyzed. Table 3 presents the descriptive statistics for participant 
pinprick pain ratings in the primary area across tDCS conditions. 
Table 3 
Descriptive Statistics of Pain Ratings to Pinprick in the Primary Area at Time 1 and 
Time 2 Across All TDCS Conditions 
              Time 1              Time 2 
tDCS  
Condition 
M (SD) 95% CI M (SD) 95% CI 
M1 & 
DLPFC 
1.40 (0.99) [0.93, 1.87] 1.63 (1.23) [1.05, 2.20] 
M1 1.25 (1.06) [0.76, 1.75] 1.25 (1.19) [0.69, 1.81] 
DLPFC 1.29 (1.18) [0.74, 1.84] 1.33 (0.94) [0.89, 1.76] 
Sham 1.45 (1.16) [0.91, 1.99] 1.20 (1.08) [0.69, 1.71] 
Note. M = mean; SD = standard deviation; CI = confidence interval.  
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Table 4 presents the descriptive statistics for participant pinprick pain ratings 
in the secondary area across tDCS conditions. 
Table 4 
Descriptive Statistics of Pain Ratings to Pinprick in the Secondary Area at Time 1 
and Time 2 Across All TDCS Conditions 
              Time 1              Time 2 
tDCS  
Condition 
M (SD) 95% CI M (SD) 95% CI 
M1 & 
DLPFC 
1.48 (1.30) [0.87, 2.08] 1.20 (1.12) [0.68, 1.72] 
M1 1.10 (0.97) [0.65, 1.55] 1.24 (1.01) [0.76, 1.71] 
DLPFC 1.28 (1.18) [0.73, 1.83] 1.50 (1.05) [1.01, 1.99] 
Sham 1.23 (1.14) [0.69, 1.76] 1.18 (0.85) [0.78, 1.57] 
Note. M = mean; SD = standard deviation; CI = confidence interval.  
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A one-way repeated measures ANOVA was used to compare participants’ 
pain ratings to pinprick within the primary and secondary areas at Time 1 and Time 2 
across all tDCS conditions.  
Primary area pinprick pain ratings  
Figure 6. Estimated marginal means for primary area pinprick pain ratings at Time 1 
and Time 2 across M1 & DLPFC, M1, DLPFC and Sham conditions.  
Figure 6 demonstrates Sham was the only condition that elicited a reduction in 
primary pain ratings post tDCS. There was no change within M1 and DLPFC 
conditions and an increase in the M1 & DLPFC condition. However, these differences 
were non-significant.   
The ANOVA results show that pinprick pain ratings within the primary area 
did not vary statistically significantly between tDCS condition F(3, 57) = 0.51, p = 
.677, η2 = .03, Time F(1, 19) = 0.001, p = .979, η2 = .00 or the interaction between 
tDCS condition and time F(3, 57) = 0.88, p = .456, η2 = .04. These results indicate the 
tDCS condition had no effect on participants’ primary area pain ratings.  
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Secondary area pinprick pain ratings  
Figure 7. Estimated marginal means for secondary area pinprick pain ratings at Time 
1 and Time 2 across M1 & DLPFC, M1, DLPFC and Sham conditions.  
Figure 7 demonstrates M1 & DLPFC was the only condition that elicited a 
reduction in secondary area pain ratings post tDCS. An increase was observed across 
all other conditions. However, these differences were non-significant. 
The ANOVA results indicate that pinprick pain ratings within the secondary 
area did not vary statistically significantly between tDCS condition F(2.30, 43.77) = 
2.32, p = .103, η2 = .11, Time F(1, 19) = 0.09, p = .765, η2 = .005 or the interaction 
between tDCS condition and time F(3, 57) = 0.99, p = .405, η2 = .05. These results 
indicate the tDCS condition had no effect on participants’ secondary area pain ratings.  
 
Discussion 
This study aimed to clarify the conflicting literature regarding whether a-tDCS 
at M1 and DLPFC reduces pain in healthy adults. Additionally, it aimed to identify 
whether concurrent a-tDCS of M1 and DLPFC results in a greater reduction of pain 
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than stimulation of each brain region alone. The findings of this study suggest 20 
minutes of 1 mA a-tDCS at M1 and DLPFC concurrently, at M1 alone and DLPFC 
alone, does not reduce experimental pain induced by-low frequency electrical 
stimulation in healthy participants. These results are somewhat consistent with the 
literature, due to the conflicting nature of current evidence (Boggio et al., 2008; Ihle 
et al., 2014; Meeker et al., 2019; Mylius et al., 2012; Zandieh et al., 2013). 
Hypothesis One 
The hypothesis that a-tDCS at M1 and DLPFC concurrently would result in 
lower pain ratings to pinprick in the primary and secondary area and the highest 
electrical current during electrical stimulation to elicit moderate pain than M1 alone, 
DLPFC alone and sham conditions was not supported. A very recent study, Henriques 
et al. (2019), compared the administration of 20 minutes 2 mA a-tDCS to M1 and 
DLPFC concurrently, with 20 minutes of 2 mA c-tDCS at M1 and a-tDCS to DLPFC 
concurrently. Results indicated a-tDCS at both M1 and DLPFC did not reduce healthy 
participants pain, whereas c-tDCS at M1 and a-tDCS at DLPFC reduced pain. 
However, due to methodological differences, direct comparisons with our study 
cannot be made. Firstly, Henriques et al. (2019) tested on 10 male participants. Our 
participant sample included both males and females. Secondly, they administered a 2 
mA current to each brain region, whereas our study applied 1 mA. Thirdly, pain was 
not experimentally induced; rather participants rated pain perception on a subjective 
rating scale in response to hip flexion and range of motion exercise tolerances.  The 
decrease of participant pain in the M1 c-tDCS and DLPFC a-tDCS montage may be 
explained by findings suggesting c-tDCS at M1 increases hip range of motion 
(Henriques et al., 2019; Lins, Lattari, Monteiro, Albuquerque Maranhāo Neto & 
Machado, 2019). If hip flexibility increases due to c-tDCS at M1, it would be 
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expected subsequent pain ratings in response to the same degree of hip flexion would 
decrease, therefore, this method of pain assessment may not be a true assessment of 
participant pain thresholds. However, without objectively testing this, definitive 
conclusions cannot be made. No other known studies have reported on healthy 
participants pain following tDCS administered to M1 and DLPFC concurrently. Due 
to the limited research within this area, future studies should replicate our study 
design but incorporate c-tDCS montages to establish whether alternative tDCS 
parameters may effectively reduce pain in healthy participants.  
Hypotheses Two and Three 
The hypotheses that a-tDCS at M1 alone, or DLPFC alone would result in 
lower pain ratings to pinprick in the primary and secondary areas and a higher current 
level during electrical stimulation to elicit moderate pain than sham, was not 
supported. As the results of prior studies are mixed, our results somewhat contradict 
the literature. Zandieh et al. (2013), who reported a reduction in participants’ pain 
following a-tDCS at M1, utilized a similar sample size, of 22 participants, and 
stimulation duration of 20 minutes. However, Zandieh et al. (2013) administered 2 
mA of a-tDCS, whereas our study applied 1 mA. Additionally, pain was assessed by a 
cold pressor test by recording the duration participants were able to withstand their 
arm submerged into water at 3°C. Mylius et al. (2012) also observed a reduction of 24 
participants pain following 20 minutes of 2 mA a-tDCS at DLPFC. Pain was assessed 
by recording participants’ tolerance thresholds to cold and heat stimuli. Again, the 
current intensity of a-tDCS and pain assessment procedures differs from our study. 
Ihle et al. (2014) reported no reduction to participants’ pain by applying the same 
current intensity of 1 mA a-tDCS at M1, as our study. Ihle et al. (2014) assessed pain 
post a-tDCS by recording responses to pinprick and pain tolerances to heat stimuli. 
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Our findings are consistent with this study, however a direct comparison cannot be 
made due to the shorter stimulation duration of 15 minutes. Meeker et al. (2019) also 
administered a-tDCS of 1 mA at M1 for 20 minutes to 15 participants, similar to our 
study. Participants pain to pinprick and heat stimuli decreased, contradicting the 
results of Ihle et al. (2014) and our study. Additionally, most prior studies 
administered a-tDCS via 35 cm2 electrodes, however the electrodes within our study 
were 25 cm2 (Zandieh et al., 2013; Boggio et al., 2008; Meeker et al., 2019). The 
methodological differences of a-tDCS current intensities, electrode size, experimental 
pain models and stimulation duration may explain the diverging findings of the 
literature.  
To maintain the integrity of the sham procedure and minimize side effects to 
participants, tDCS at the current intensity of 1 mA was selected within this study 
(Bastani & Jaberzadeh, 2013; Gandiga, Hummel & Cohen, 2006). However, most 
prior studies that obtained a significant reduction in healthy participants’ pain 
administered 2 mA to M1 and DLPFC (Zandieh et al., 2013; Boggio et al., 2008; 
Meeker et al., 2019). The literature indicates the strength of the electrical current 
induces different levels of cortical excitability (Bastani & Jaberzadeh, 2013; Nitsche 
& Paulus, 2000). The results of prior tDCS studies applying 2 mA could suggest the 1 
mA current utilized within our study may provide an explanation for the non-
significant results obtained. However, a study conducted by Ho et al. (2016), who 
directly tested cortical excitability differences between 1 mA and 2 mA a-tDCS at 
M1, found no significant difference in excitability between current strengths. Despite 
no difference in cortical excitability, 2 mA might be more effective at reducing 
participants’ pain. It is important to consider, the studies that utilized 2 mA did not 
report the success of participant blinding to the sham condition. Current intensities of 
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2 mA may compromise participant blinding, which could influence results obtained 
(Horvath, Carter & Forte, 2014; O’Connell et al., 2018). To clarify whether 2 mA a-
tDCS results in greater pain reduction than 1 mA, future research needs to directly 
compare currents intensities and success of participants blinding in a sham controlled 
study.   
Anodal electrodes of 25 cm2 were selected for this study as smaller electrodes 
stimulate a more focal area, minimizing stimulation of adjacent sites; and to blind 
participants to active tDCS (Gandiga et al., 2006; Thair et al., 2017). The literature 
indicates larger stimulating electrodes will produce greater tDCS sensations, 
compromising blinding (O’Connell et al., 2012; Palm et al., 2013). However, prior 
studies reporting a reduction in participants’ pain following a-tDCS at M1 and 
DLPFC have utilized 35 cm2 electrodes (Boggio et al., 2008; Meeker et al., 2019; 
Mylius et al., 2012; Zandieh et al., 2013). The literature suggests the size of the 
stimulating electrode influences the level of induced cortical excitability (Nitsche & 
Paulus, 2000). Ho et al. (2016) measured and compared excitability induced by 16 
cm2 and 35 cm2 electrodes during a-tDCS. Results indicated the 35cm2 electrode 
induced significantly greater cortical excitability (Ho et al., 2016).  It can be 
speculated that the smaller sized electrode utilized by our study may not have induced 
the same level of cortical excitability as prior studies utilizing 35cm2 electrodes. 
However, direct comparisons between 25 cm2 and 35cm2 electrodes have not been 
made. Before definitive conclusions can be drawn, future studies need to assess 
whether 35 cm2 electrodes elicit greater pain reduction than 25 cm2 electrodes during 
a-tDCS at M1 and DLPFC. Additionally, future studies need to report the success of 
participant blinding to accurately assess whether any reported decrease in pain is 
greater than placebo.  
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 The low-frequency electrical stimulation pain model was selected for this 
study as it evokes both primary and secondary hyperalgesia, which are characteristics 
of chronic pain (Beissner et al., 2010; Liu & Sandkühler, 1997; Ziegler, et al., 1999). 
No known study has employed low-frequency electrical stimulation to assess pain 
responses following tDCS. Most prior studies reporting a reduction to participants’ 
pain utilized cold and heat stimuli (Ihle et al., 2014; Meeker et al., 2019; Mylius et al., 
2012; Zandieh et al., 2013). The different pain model utilized in our study may 
explain the contradicting findings.  To clarify this, future studies should compare pain 
responses to thermal stimuli with low-frequency electrical stimulation following 
tDCS.  
Alternative Explanations  
Similar pain ratings to pinprick, and a significant increase in the current level 
required to elicit moderate pain was observed after tDCS irrespective of the brain 
region(s) stimulated. Suggesting that 20 minutes of a-tDCS at 1mA did not reduce 
pain. Habituation to the electrical stimuli may explain the significant increase in 
current level required to induce moderate level pain post tDCS (Bauch, Andreou, 
Rausch & Bunzeck, 2017). Habituation is a neural response, where exposure to 
repetitive nociceptive stimuli decreases pain over time (Bauch, et al., 2017; Milne et 
al., 1991). However, this process is only observed with low to moderate intensity pain 
stimuli (Ginzburg et al., 2015).  Habituation is an adaptive process of the pain 
modulation system, which inhibits pain once the initial warning signal to the painful 
stimuli has been received (Bauch et al., 2017; Bingel, Schoell, Herken, Büchel & 
May, 2007; Ginzburg et al., 2015). A study conducted by Milne et al. (1991) indicated 
that two minutes of low intensity electrical stimulation at 1 Hz frequency and a 0.5 ms 
pulse width induced habituation to the stimuli. Additionally, Ginzburg et al. (2015) 
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observed that participants reported lower pain ratings following 60 seconds of 
electrical stimulation. Our participants were exposed to over 60 seconds of low-
frequency electrical stimulation at 1 Hz and 0.5 ms pulse width to achieve moderate 
pain at baseline and after tDCS, which might have been sufficient to induce 
habituation, resulting in the significant increase in current level required to induce 
moderate pain after tDCS (Ginzburg et al., 2015; Milne et al., 1991).  
Nickel et al. (2014) examined brain correlates of habituation to low-frequency 
electrical stimulation identical to the parameters of this study, by recording BOLD 
responses via fMRI. BOLD responses obtained during electrical stimulation indicated 
habituation modulated neuronal activity within brain regions associated with pain, 
including the DLPFC and thalamus (Nickel et al., 2014). As it is suggested a-tDCS at 
M1 may influence thalamic blood flow, which is potentially responsible for the 
decrease in pain observed following stimulation, habituation may have biased the data 
collected within this study (Garcia-Larrea et al., 1999; Saitoh et al., 2001). Neuro-
modulation during habituation to the electrical stimuli may have confounded results 
obtained, as it potentially influenced participants’ pain perception. Therefore, any 
potential subtle effects of tDCS on pain within our study could not be observed. To 
eliminate this confounding variable, future studies should assess pain via measures 
that are reliable and consistent within and between experimental sessions, such as 
electronic pressure algometry applied to the C6 spinal segment (Frank, McLaughlin & 
Vaughan, 2013; Vatine, Shapira, Magora, Alder & Magora, 1993). Electronic 
pressure algometry objectively quantifies pain pressure thresholds in healthy 
participants via the application of a constant rate of 1 kg/s pressure; participants press 
a button when the pressure sensation changes to pain (Frank et al., 2013; Petersen-
Felix & Arendt-Nielsen, 2002; Potter, McCarthy & Oldham, 2006). Prior studies 
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indicate this pain assessment method triggers nociceptive responses whilst providing 
high intra-rater and test-retest reliability, with consistent ratings obtained both five 
minutes and one week apart (Frank et al., 2013; Potter et al., 2006; Vatine et al., 
1993). These findings indicate, that if any habituation to the pressure stimulus has 
occurred, these effects are non-significant, minimizing bias to obtained pain ratings.  
In addition to habituation, female participants menstrual cycles could have 
influenced results (Iacovides, Avidon & Baker, 2015; Riley Iii, Robinson, Wise & 
Price, 1999). Tassorelli et al. (2002) examined nociceptive flexion reflexes, an 
objective measure of fluctuations within the pain control system, and VAS pain 
ratings, in response to high-frequency electrical stimulation administered to women 
during the different stages of their menstrual cycle. Results demonstrated women 
were more sensitive to painful electrical stimulation in their mid to late luteal phase 
(days six to eight from ovulation) than their follicular phase (eight to 10 days from the 
first day of menstrual bleeding; Tassorelli et al., 2002). This pain sensitivity during 
the luteal phase has been demonstrated in other studies (Fillingim et al., 1997; 
Pfleeger, Straneva, Fillingim, Maixner & Girdler, 1997; Riley Iii et al., 1999). 
Although the exact mechanism is unclear, it is speculated the fluctuation of sex 
hormones estrogen and progesterone during the menstrual cycle may influence pain 
perception, which might have altered the results of the present study by influencing 
pain thresholds (Basbaum & Fields, 1984; Facchinetti et al., 1988; Tassorelli et al., 
2002). Additionally, it is argued, estrogen might impact serotogenic pathways (a 
neurotransmitter implicated with pain) by controlling excitability at the brain stem, 
which projects inhibitory or facilitatory pain mechanisms to the spinal cord (Bannister 
& Dickenson, 2017; Taylor, Mathew, Ho & Weinman, 1984; Yarnitsky, 2015).  
Therefore, the neuromodulation effect of tCDS may be implicated in the luteal phase 
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due to its influence on descending pain mechanisms. As 50% of our sample was 
female and menstrual cycle was not controlled, this could have significantly 
influenced the results obtained. To minimize this potential confounding variable, 
future studies should test females during the same period of their menstrual cycle 
(Tassorelli et al., 2002; Riley Iii et al., 1999).  
Limitations  
The methodology of the current study needs to be considered in the context of 
prior research findings to interpret results obtained. The current study employed the 
VAS rating scale to rate participants’ level of pain. Although the VAS is considered a 
valid and reliable measure of pain utilized within pain studies, the measure is based 
on participant subjective ratings (Kane, Bershadsky, Rockwood, Saleh & Islam, 2005; 
Price, McGrath, Rafii & Buckingham, 1983; Rosen, Ramkumar, Nguyen & Hoeft, 
2009). Incorporating an objective measure of pain alongside the VAS within the study 
may have captured changes in participants’ pain sensations not demonstrated by the 
VAS. To address this limitation, future studies should incorporate objective measures 
to capture decreases in pain that may not be evident through the use of the VAS alone. 
A suggested measure is the recording of the nociceptive flexion reflex, a 
physiological withdrawal response to painful stimuli, which has been established as a 
reliable, and objective measure of pain, that is easily measurable within clinical 
settings (Skljarevski & Ramadan, 2002; Tassorelli et al., 2002).  
An additional limitation of the current study was the small sample size. Our 
methodological decision to test 20 participants was based on past tDCS studies 
obtaining significant results with similar sample sizes and the one-year timeframe 
established for this study (Zandieh et al., 2013; Boggio et al., 2008; Meeker et al., 
2019). Future studies should increase statistical power by employing larger participant 
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samples, reducing the risk of falsely rejecting the null hypothesis, committing a type I 
error (Field, 2015).  A further limitation was the four tDCS operators measuring 
participants’ scalps to determine the location of target brain regions. The present 
study used the 10/20 EEG system to locate M1 and DLPFC brain regions (DaSilva et 
al., 2011). All experimenters were trained to use this system by an experienced 
researcher. However, it cannot be completely ruled out that scalp measurements 
obtained by different experimenters were not consistent, which might have caused 
inconsistent stimulation of cortical areas across testing sessions. To mitigate potential 
inconsistencies of locating brain regions, future studies should ensure only one 
suitably trained researcher locates cortical targets.  
Future Directions  
 Future research replicating our study is needed to determine whether a-tDCS 
of M1 and DLPFC reduces pain, and whether concurrent stimulation results in greater 
pain reduction. This is required due to current conflicting findings and limited 
published literature exploring concurrent stimulation of M1 and DLPFC for pain 
reduction. Given that a-tDCS at 1 mA did not reduce pain, a 2 mA current should be 
considered. However, studies need to report whether participant blinding is successful 
to determine whether any observed reduction in pain is not due to placebo (Gandiga et 
al., 2006; O’Connell et al., 2018). Future studies should assess whether larger 
electrode sizes of 35 cm2 induce greater pain reduction than 25 cm2 during tDCS. 
Studies should incorporate objective measures of pain, such as recordings of the 
nociceptive flexion reflex or objective pain rating tools such as electronic pressure 
algometry in their designs, to capture any potential subtle decreases in pain following 
tDCS that subjective pain measures such as the VAS will not reveal (Petersen-Felix & 
Arendt-Nielsen, 2002; Tassorelli et al., 2002). To minimize habituation effects of pain 
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stimuli during the experimental procedure, pain ratings should be obtained by 
electronic pressure algometry applied to the C6 spinal segment (Frank et al., 2013; 
Potter et al., 2006; Vatine et al., 1993). Lastly, testing on female participants should 
occur during the same period of their menstrual cycle to minimize this potential 
confounding factor biasing results (Tassorelli et al., 2002).  
Conclusion  
 The current study investigated tDCS as a potential treatment for chronic pain 
by administering 1 mA a-tDCS for 20 minutes to brain regions M1 and DLPFC 
concurrently, M1 alone, DLPFC alone and sham to healthy participants. Participant 
VAS pain ratings to primary and secondary area pinpricks and current level during 
low-frequency electrical stimulation to elicit moderate pain were not significantly 
different between tDCS conditions. These results indicate tDCS did not reduce 
participants’ pain within this study. However, electric current level to elicit pain was 
statistically significant between pre and post tDCS, suggesting participant habituation 
to the low-frequency electrical stimulation may have biased results obtained (Bauch, 
et al., 2017; Milne et al., 1991). Additionally, no objective measures assessed 
potential subtle changes of pain resulting from tDCS. Prior literature suggests the 
administration of 2 mA a-tDCS utilizing 35 cm2 anodal electrodes might decrease 
participants pain, however, these studies have not assessed whether participants were 
blinded to sham (Boggio et al., 2008; Meeker et al., 2019; Mylius et al., 2012; 
Zandieh et al., 2013).  Future research should replicate this study to determine 
whether tDCS reduces healthy participants pain by administering 2 mA of a-tDCS for 
20 minutes with 35 cm2 anodal electrodes. Studies should report whether participants 
are successfully blinded to sham, to assess whether any observed decrease in 
participants’ pain is greater than placebo. Additionally, to minimize habituation 
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effects and to obtain objective pain related data, electronic pressure algometry 
administered to the C6 spinal segment should be utilized to measure participants’ 
pain. Limitations of our study and the current literature need to be addressed in 
replication studies before definitive conclusions as to the efficacy of a-tDCS at M1 
and DLPFC for the treatment of chronic pain can be made.  
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